Patents Act 1970

Overview

The Patents Act 1970, including its TRIPS-compliant amendments, forms the foundational legal framework governing patents in India. It defines patent rights, eligibility, application procedures, and exclusive rights granted to inventors, balancing innovation promotion with public interest.

Introduction

The Patents Act, 1970 was enacted to consolidate and amend laws related to patents in India. It extends to the whole of India and sets out the framework for patentability, application, examination, grant, and enforcement of patents. The Act initially focused on process patents for pharmaceuticals and agro-chemicals and product patents generally for other fields.

Key Provisions of the Patents Act

• Patent Eligibility: The Act requires inventions to be novel, involve inventive steps, and be industrially applicable. Inventions must not be ineligible under Sections 3 and 4, such as discoveries, scientific theories, business methods, mathematical methods, plant or animal varieties (except microbiological processes), or mere aesthetic creations.
• Rights Conferred: A patent grants the holder exclusive rights to prevent others from making, using, selling, or importing the patented product or process for 20 years from the filing date.
• Application Process: The Act outlines procedures for filing applications, examination, opposition, and grant of patents, with provisions for provisional specifications and priority claims.
• Government Use: The Central Government has powers to use patented inventions for government purposes under specified conditions, notably to safeguard public interest in health.

TRIPS Agreement and Indian Patent Law Amendments

India became a World Trade Organization (WTO) member in 1995 and a signatory to the Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS). To comply, India undertook phased amendments in 1999, 2002, and 2005 to harmonize patent laws with TRIPS requirements.

Major TRIPS-Compliance Amendments

• 1999 Amendment: Introduced product patents for pharmaceuticals and agro-chemicals, replacing earlier process-only patents in these sectors. It introduced exclusive marketing rights and expanded patent coverage, setting a transition path to full TRIPS compliance.
• 2002 Amendment: Further aligned patentability criteria with TRIPS by redefining patentable subject matter, extending patent term protection to 20 years, and revising compulsory licensing provisions with safeguards for public interest.
• 2005 Amendment: Finalized India’s TRIPS compliance by fully implementing product patent protection in pharmaceuticals and other technology fields, adjusting legal provisions concerning patent enforcement, and compulsory license mechanism to balance patent monopoly and public health needs.

Impact of TRIPS-Compliant Amendments

• Product Patent Regime: Shift from process patents to product patents in pharmaceuticals improved intellectual property protection but raised debates regarding drug affordability and access.
• Compulsory Licensing: Provisions allow government intervention to issue licenses without the patent holder’s consent under emergencies, public health crises, or unfair pricing, balancing innovation with societal needs.
• Patent Term: Uniform 20-year patent term from the filing date aligns India’s patent duration with international norms.
• Enhanced Clarity: Detailed definitions and procedures streamlined patent filing, examination, and dispute resolution consistent with global standards.

Download as PDF